Добавить новость
smi24.net
World News in Dutch
Апрель
2017

Новости за 24.04.2017

Hasbro tops Street 1Q forecasts

«TDN» (tdn.com) 

PAWTUCKET, R.I. (AP) — Hasbro Inc. (HAS) on Monday reported first-quarter profit of $68.6 million.

Hasbro tops Street 1Q forecasts

«La Crosse Tribune» (lacrossetribune.com) 

PAWTUCKET, R.I. (AP) — Hasbro Inc. (HAS) on Monday reported first-quarter profit of $68.6 million.

Venezuela's Government Unable to Stop Protests

Voice of America 

Despite intense police and military activity, hundreds of thousands of Venezuelans have demonstrated through the big cities against the government of President Nicolás Maduro. Violent clashes between security forces and other paramilitary forces with protesters as well as riots have left dozens injured, about 270 detained and at least 12 dead.

Halliburton reports 1Q loss

TheRepublic.com 

HOUSTON — Halliburton Co. (HAL) on Monday reported a loss of $32 million in its first quarter. On a per-share basis, the Houston-based company said it had a loss of 4 cents. Earnings, adjusted to extinguish debt, were 4 cents per share. The results exceeded Wall Street expectations. The average estimate of 14 analysts surveyed



Murder charges after toddler dies of 'head trauma'

CTVNews.ca 

Second-degree murder charges have been laid against a father and his girlfriend after the badly bruised body of a toddler was found outside a church in Edmonton. Police said that Anthony Joseph Raine, 19 months, died of head trauma and was found with “bruises all over his body.”

Halliburton reports 1Q loss

«TDN» (tdn.com) 

HOUSTON (AP) — Halliburton Co. (HAL) on Monday reported a loss of $32 million in its first quarter.

Halliburton reports 1Q loss

«La Crosse Tribune» (lacrossetribune.com) 

HOUSTON (AP) — Halliburton Co. (HAL) on Monday reported a loss of $32 million in its first quarter.

Qatar Airways sees 'manageable' decline in flights to US

«Gazette Times» (gazettetimes.com) 

DUBAI, United Arab Emirates (AP) — The CEO of one of the Middle East's largest carriers said Monday passenger numbers to the United States have dipped slightly over fears by some Muslim passengers that their visas may be rejected upon…

Qatar Airways sees 'manageable' decline in flights to US

«TDN» (tdn.com) 

DUBAI, United Arab Emirates (AP) — The CEO of one of the Middle East's largest carriers said Monday passenger numbers to the United States have dipped slightly over fears by some Muslim passengers that their visas may be rejected upon…

Qatar Airways sees 'manageable' decline in flights to US

«La Crosse Tribune» (lacrossetribune.com) 

DUBAI, United Arab Emirates (AP) — The CEO of one of the Middle East's largest carriers said Monday passenger numbers to the United States have dipped slightly over fears by some Muslim passengers that their visas may be rejected upon…

Ghana, Kenya, Malawi to Test First Malaria Vaccine

Voice of America 

The World Health Organization has chosen Ghana, Kenya and Malawi as the countries where the world's first malaria vaccine will be tested next year on young children. The injectable vaccine, known as RTS,S, or Mosquirix, was developed by the British pharmaceutical company, GlaxoSmithKline. The test will be conducted on babies and toddlers, aged 5 to 17 months. Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female mosquitoes. Читать дальше...

Italian Journalist Home After 2 Weeks Detention in Turkey

Voice of America 

An Italian journalist has returned to Italy after being detained for two weeks in Turkey, apparently because he entered an area near the Syrian border without proper permission. Gabriele Del Grande, a blogger and documentary maker who has written about refugees, was detained after entering the area of Hatay in southern Turkey. He arrived Monday at Bologna airport on a flight from Turkey. He said he had been treated well but wanted to know why he was deprived of his freedom for 14 days "for doing... Читать дальше...

Akari Therapeutics stock rises 10% on positive mid-stage trial results

MarketWatch.com 

Akari Therapeutics PLC shares surged as much as 9.7% in premarket trade Monday after the company said its drug for a rare blood disease had positive results in a mid-stage clinical trial. The drug, Coversin, is intended to treat paroxysmal nocturnal hemoglobinuria, a dangerous blood disease that typically affects younger adults. Five patients were enrolled in the phase 2 trial, which lasted 90 days and tested the drug's safety and efficacy. Four of those patients remain on the drug, symptom-free and without any serious adverse events... Читать дальше...





СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *